DE69420832T2 - Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8 - Google Patents

Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8

Info

Publication number
DE69420832T2
DE69420832T2 DE69420832T DE69420832T DE69420832T2 DE 69420832 T2 DE69420832 T2 DE 69420832T2 DE 69420832 T DE69420832 T DE 69420832T DE 69420832 T DE69420832 T DE 69420832T DE 69420832 T2 DE69420832 T2 DE 69420832T2
Authority
DE
Germany
Prior art keywords
inhibiting
interleukin
pct
production
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69420832T
Other languages
English (en)
Other versions
DE69420832D1 (de
Inventor
Takahide Matsuda
Shigeru Owada
Hiroshi Muta
Miki Aihara
Hisao Takizawa
Ken-Ichi Imagawa
Mikio Kikuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69420832D1 publication Critical patent/DE69420832D1/de
Publication of DE69420832T2 publication Critical patent/DE69420832T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
DE69420832T 1993-10-21 1994-10-17 Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8 Expired - Lifetime DE69420832T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP26341893 1993-10-21
JP26341993 1993-10-21
JP26341793 1993-10-21
JP8964194 1994-04-27
PCT/JP1994/001739 WO1995011026A1 (en) 1993-10-21 1994-10-17 Carbostyril derivative for inhibiting production of interleukin-8

Publications (2)

Publication Number Publication Date
DE69420832D1 DE69420832D1 (de) 1999-10-28
DE69420832T2 true DE69420832T2 (de) 2000-01-13

Family

ID=27467652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69420832T Expired - Lifetime DE69420832T2 (de) 1993-10-21 1994-10-17 Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8

Country Status (14)

Country Link
US (1) US5637597A (de)
EP (1) EP0674515B1 (de)
JP (1) JP2839847B2 (de)
KR (1) KR100191191B1 (de)
CN (1) CN1073418C (de)
AT (1) ATE184793T1 (de)
AU (1) AU683697B2 (de)
CA (1) CA2150546C (de)
DE (1) DE69420832T2 (de)
DK (1) DK0674515T3 (de)
ES (1) ES2138092T3 (de)
GR (1) GR3032091T3 (de)
TW (1) TW296983B (de)
WO (1) WO1995011026A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10029404A1 (de) * 2000-06-15 2002-01-03 Johannes Wohlrab Arzneiformulierung enthaltend Ciclosporin und deren Verwendung

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
US7408078B2 (en) * 2002-10-08 2008-08-05 Wyeth Anthranilic acid derivatives useful in treating infection with hepatitis C virus
WO2005011811A1 (en) * 2003-07-30 2005-02-10 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives for accelerating salivation
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
KR101551506B1 (ko) * 2007-08-10 2015-09-08 오츠카 세이야쿠 가부시키가이샤 레바미피드를 함유하는 의약 조성물
KR101104634B1 (ko) * 2009-08-25 2012-01-12 한림제약(주) 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물
KR101182114B1 (ko) * 2010-03-05 2012-09-12 한림제약(주) 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
UA114600C2 (uk) 2011-03-24 2017-07-10 Оцука Фармасьютікал Ко., Лтд. Фармацевтична композиція для лікування захворювання у порожнині рота, що містить ребаміпід
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS63119467A (ja) * 1987-10-21 1988-05-24 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPH02178227A (ja) * 1988-12-28 1990-07-11 Otsuka Pharmaceut Co Ltd 腎炎治療剤
JP2812998B2 (ja) * 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
KR0180248B1 (ko) * 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 항당뇨병약품
CA2090876A1 (en) * 1991-07-03 1993-01-04 Satoru Nakai Apoptosis regulating composition
TW227558B (de) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
AU5715994A (en) * 1992-12-24 1994-07-19 Otsuka Pharmaceutical Co., Ltd. Psoriasis remedy
JP3054743B2 (ja) * 1993-03-02 2000-06-19 大塚製薬株式会社 移植組織の拒絶反応抑制剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10029404A1 (de) * 2000-06-15 2002-01-03 Johannes Wohlrab Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung

Also Published As

Publication number Publication date
CA2150546A1 (en) 1995-04-27
ES2138092T3 (es) 2000-01-01
TW296983B (de) 1997-02-01
EP0674515B1 (de) 1999-09-22
CN1073418C (zh) 2001-10-24
KR100191191B1 (ko) 1999-06-15
AU683697B2 (en) 1997-11-20
AU7864194A (en) 1995-05-08
KR950703957A (ko) 1995-11-17
US5637597A (en) 1997-06-10
EP0674515A1 (de) 1995-10-04
CA2150546C (en) 2004-11-09
WO1995011026A1 (en) 1995-04-27
JPH0812578A (ja) 1996-01-16
ATE184793T1 (de) 1999-10-15
DE69420832D1 (de) 1999-10-28
CN1117268A (zh) 1996-02-21
GR3032091T3 (en) 2000-03-31
JP2839847B2 (ja) 1998-12-16
DK0674515T3 (da) 1999-12-20

Similar Documents

Publication Publication Date Title
DE69420832T2 (de) Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
DE69521424T2 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE69418243T2 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
HUP0303639A2 (hu) Új amlodipin-kamzilát és eljárás annak előállítására
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
ATE217616T1 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
ATE232387T1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
TW429146B (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
DE69430427T2 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
ATE232097T1 (de) Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen
AU655869B2 (en) An amphoteric tricyclic compound
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition